Sort   by:  
 Page size 
UnknownA randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Not available
S-EPMC4922318 | biostudies-literature
UnknownUpdated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer.
Not available
S-EPMC6212676 | biostudies-literature
UnknownPrognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial).
Not available
S-EPMC7960987 | biostudies-literature
UnknownEfficacy and Long-term Peripheral Sensory Neuropathy of 3 vs 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Colon Cancer: The ACHIEVE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC6743062 | biostudies-literature
UnknownPoor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine-induced toxicity in an Asian population.
Not available
S-EPMC10134304 | biostudies-literature
UnknownFive-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Not available
S-EPMC10236623 | biostudies-literature
Sort   by:  
 Page size